CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
78 hedge funds and large institutions have $168M invested in Cascadian Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
Holders
78
Holding in Top 10
2
Calls
$741K
Puts
–
Top Buyers
| 1 | +$30.1M | |
| 2 | +$18.9M | |
| 3 | +$16.9M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$12.4M |
| 5 |
A
Abingworth
London,
United Kingdom
|
+$3.83M |
Top Sellers
| 1 | -$2.22M | |
| 2 | -$142K | |
| 3 | -$108K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$96.1K |
| 5 |
EWM
Edge Wealth Management
New York
|
-$85K |